Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Macular Society is a leading UK-based health charity and patient advocacy organization dedicated to supporting individuals with macular disease and funding research to find a cure. Established in 1987, the society provides a wide range of services, including a national helpline, local support groups, and advocacy for better access to treatments. As a significant funder of ophthalmic research, the organization awards grants to leading academic institutions to investigate the causes and potential therapies for age-related macular degeneration (AMD) and rare inherited macular dystrophies. The Macular Society also collaborates with the pharmaceutical industry and healthcare providers to ensure the patient voice is represented in clinical trial design and health policy. It is the largest membership group for people with macular disease in the UK and plays a critical role in raising public awareness about the impact of central vision loss.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Macular Society.